These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27496950)

  • 1. Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype.
    McCammon KM; Panda SP; Xia C; Kim JJ; Moutinho D; Kranendonk M; Auchus RJ; Lafer EM; Ghosh D; Martasek P; Kar R; Masters BS; Roman LJ
    J Biol Chem; 2016 Sep; 291(39):20487-502. PubMed ID: 27496950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
    Jin Y; Chen M; Penning TM; Miller WL
    Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
    Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P450 oxidoreductase deficiency: a disorder of steroidogenesis with multiple clinical manifestations.
    Miller WL
    Sci Signal; 2012 Oct; 5(247):pt11. PubMed ID: 23092891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered human CYP3A4 activity caused by Antley-Bixler syndrome-related variants of NADPH-cytochrome P450 oxidoreductase measured in a robust in vitro system.
    Moutinho D; Marohnic CC; Panda SP; Rueff J; Masters BS; Kranendonk M
    Drug Metab Dispos; 2012 Apr; 40(4):754-60. PubMed ID: 22252407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism.
    Flück CE; Mullis PE; Pandey AV
    Biochem Biophys Res Commun; 2010 Oct; 401(1):149-53. PubMed ID: 20849814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase.
    Velazquez MNR; Parween S; Udhane SS; Pandey AV
    Biochem Biophys Res Commun; 2019 Jul; 515(1):133-138. PubMed ID: 31128914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.
    Huang N; Pandey AV; Agrawal V; Reardon W; Lapunzina PD; Mowat D; Jabs EW; Van Vliet G; Sack J; Flück CE; Miller WL
    Am J Hum Genet; 2005 May; 76(5):729-49. PubMed ID: 15793702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
    Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Tomalik-Scharte D; Maiter D; Kirchheiner J; Ivison HE; Fuhr U; Arlt W
    Eur J Endocrinol; 2010 Dec; 163(6):919-24. PubMed ID: 20844025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambiguous genitalia, impaired steroidogenesis, and Antley-Bixler syndrome in a patient with P450 oxidoreductase deficiency.
    But WM; Lo IF; Shek CC; Tse WY; Lam ST
    Hong Kong Med J; 2010 Feb; 16(1):59-62. PubMed ID: 20124576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children.
    Fan L; Ren X; Song Y; Su C; Fu J; Gong C
    Orphanet J Rare Dis; 2019 Dec; 14(1):299. PubMed ID: 31888681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 oxidoreductase deficiency caused by R457H mutation in POR gene in Chinese: case report and literature review.
    Bai Y; Li J; Wang X
    J Ovarian Res; 2017 Mar; 10(1):16. PubMed ID: 28288674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P.
    Dhir V; Ivison HE; Krone N; Shackleton CH; Doherty AJ; Stewart PM; Arlt W
    Mol Endocrinol; 2007 Aug; 21(8):1958-68. PubMed ID: 17505056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P450 oxidoreductase deficiency: a new disorder of steroidogenesis.
    Miller WL; Huang N; Pandey AV; Flück CE; Agrawal V
    Ann N Y Acad Sci; 2005 Dec; 1061():100-8. PubMed ID: 16467261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency.
    Koika V; Armeni AK; Georgopoulos NA
    Hormones (Athens); 2016 Apr; 15(2):277-282. PubMed ID: 27376429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional deletion of cytochrome p450 reductase in osteoprogenitor cells affects long bone and skull development in mice recapitulating antley-bixler syndrome: role of a redox enzyme in development.
    Panda SP; Guntur AR; Polusani SR; Fajardo RJ; Gakunga PT; Roman LJ; Masters BS
    PLoS One; 2013; 8(9):e75638. PubMed ID: 24086598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antley-Bixler syndrome or POR deficiency?].
    Tomková M; Marohnic CC; Baxová A; Martásek P
    Cas Lek Cesk; 2008; 147(5):261-5. PubMed ID: 18630181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound heterozygosity of a paternal submicroscopic deletion and a maternal missense mutation in POR gene: Antley-bixler syndrome phenotype in three sibling fetuses.
    Tzetis M; Konstantinidou A; Sofocleous C; Kosma K; Mitrakos A; Tzannatos C; Kitsiou-Tzeli S
    Birth Defects Res A Clin Mol Teratol; 2016 Jul; 106(7):536-41. PubMed ID: 26969897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of variations in human P450 oxidoreductase on the aromatase activity of CYP19A1 polymorphisms R264C and R264H.
    Parween S; DiNardo G; Baj F; Zhang C; Gilardi G; Pandey AV
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105507. PubMed ID: 31669572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.